Pharmafile Logo
Pharmafocus logo
Advanced Search

Alvogen

Showing 9 posts of 9 posts found.

facilities_lg06

Indivior launches authorised generic version of opioid addiction treatment Suboxone as rival generic drugmakers enter market

February 21, 2019
Sales and Marketing Alvogen, Dr Reddy's, Novartis, Sandoz, indivior

Indivior has announced the launch of an authorised generic version of Suboxone Film (buprenorphine/naloxone) a combination medicine used to treat …

News

Death row inmate whose execution was postponed found dead in cell

January 9, 2019
Research and Development Alvogen, Scott Dozier, execution, pharma, prison

Scott Dozier, the death row inmate whose execution was stalled by court cases launched by pharmaceutical companies, has been found …

News

Alvogen court case causes Nevada Judge to halt execution

July 13, 2018
Medical Communications Alvogen, Nevada, court, execution, lethal injection

A Nevada Judge has temporarily prevented the use of the sedative midazolam, in the execution of the twice convicted killer …

News

Cadila scores FDA approval for BMS and Alvogen generics

July 3, 2018
Manufacturing and Production, Sales and Marketing Adolat, Alvogen, Bristol-Myers Squibb, Cadila, FDA, Questran, generics, pharma

Cadila Healthcare has announced that it has gained FDA final approval to market nifedipine ER tablets in the strengths of …

News
suboxone

Indivior rocked by loss of patent case

March 23, 2018
Medical Communications, Sales and Marketing Alvogen, biotech, drugs, indivior, opioid, pharma, pharmaceutical

Indivior has been dealt a hammer blow after US District Court for the District of Delaware found in favour of …

News

First generic copy of Roche’s Tamiflu hits US market

December 12, 2016
Sales and Marketing Alvogen, Roche, Tamiflu

Drugmaker Alvogen has released the first generic version of Roche’s flu medication Tamiflu (oseltamivir) in the US, where it expects …

News
faysal_kamoua

Alvogen appoints Faysal Kalmoua as EVP of portfolio

October 29, 2015
Medical Communications Alvogen, Faysal Kalmoua

Alvogen has announced the appointment of Faysal Kalmoua as its new executive vice president of portfolio.Kalmoua joins Alvogen with an …

Appointment
alvogen_drugs_generic

Alvogen buys four-drug portfolio from Pfizer

August 27, 2015
Sales and Marketing Alvogen, Pfizer

Alvogen has entered into a agreement with Pfizer to purchase a portfolio of four pharmaceutical products for the US market, …

News

US generics company expands into Eastern Europe

January 19, 2010
Sales and Marketing Alvogen, Eastern Europe, generics

US generics company Alvogen has announced an ambitious expansion into the lucrative markets of Eastern Europe. The company has opened …

News

Latest content

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024